Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7079-7088
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7079
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7079
Figure 1 Hepatitis C genomic targets for drug development.
HCV: Hepatitis C virus; IFN: Interferon.
- Citation: Thompson JR. Emerging therapeutic options for the management of hepatitis C infection. World J Gastroenterol 2014; 20(23): 7079-7088
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7079.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7079